GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India flag India · Delayed Price · Currency is INR
2,595.80
+12.00 (0.46%)
Feb 19, 2026, 2:10 PM IST

NSE:GLAXO Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Revenue
38,00737,49234,53732,51732,78029,256
Revenue
38,00737,49234,53732,51732,78029,256
Revenue Growth (YoY)
2.59%8.56%6.21%-0.80%12.05%-9.27%
Cost of Revenue
13,82014,13913,55213,04113,78212,824
Gross Profit
24,18723,35420,98519,47618,99816,432
Selling, General & Admin
7,1767,0187,3587,0627,3976,858
Other Operating Expenses
4,0594,5244,5414,2723,9313,594
Operating Expenses
11,91512,21012,59511,99212,01011,236
Operating Income
12,27211,1438,3907,4846,9885,196
Interest Expense
-27.04-13.14-17.99-18.12-19.96-35.31
Interest & Investment Income
762.8762.8729.28698.55711.531,106
Currency Exchange Gain (Loss)
-22.66-22.66--99.07-51.36-
Other Non Operating Income (Expenses)
41.6---370.08
EBT Excluding Unusual Items
13,02711,8709,1018,0667,6666,266
Merger & Restructuring Charges
---1,633-113.7-200.84-2.4
Gain (Loss) on Sale of Investments
696.5696.5487.76307.795.92-
Gain (Loss) on Sale of Assets
-15.13-15.138.890.283.24-0.59
Asset Writedown
----2.61-2,090
Other Unusual Items
206.2246.92196.87104.02314366.44
Pretax Income
13,91512,5998,1628,3647,7904,540
Income Tax Expense
3,7053,3232,2622,2883,9831,667
Earnings From Continuing Operations
10,2109,2765,9006,0763,8082,873
Earnings From Discontinued Operations
---30.4513,140708.78
Net Income
10,2109,2765,9006,10716,9473,581
Net Income to Common
10,2109,2765,9006,10716,9473,581
Net Income Growth
18.83%57.23%-3.39%-63.97%373.19%284.26%
Shares Outstanding (Basic)
169169169169169169
Shares Outstanding (Diluted)
169169169169169169
EPS (Basic)
60.2654.7634.8336.05100.0421.14
EPS (Diluted)
60.2654.7634.8336.05100.0421.14
EPS Growth
18.84%57.23%-3.39%-63.97%373.19%284.26%
Free Cash Flow
-12,6695,5084,4027,7615,337
Free Cash Flow Per Share
-74.7832.5125.9845.8131.50
Dividend Per Share
42.00042.00032.00032.00030.00030.000
Dividend Growth
-31.25%-6.67%-50.00%
Gross Margin
63.64%62.29%60.76%59.89%57.96%56.17%
Operating Margin
32.29%29.72%24.29%23.02%21.32%17.76%
Profit Margin
26.86%24.74%17.08%18.78%51.70%12.24%
Free Cash Flow Margin
-33.79%15.95%13.54%23.68%18.24%
EBITDA
12,63211,5278,8057,8847,4285,733
EBITDA Margin
33.24%30.75%25.50%24.25%22.66%19.60%
D&A For EBITDA
359.73383.57415.36399.67439.6537.22
EBIT
12,27211,1438,3907,4846,9885,196
EBIT Margin
32.29%29.72%24.29%23.02%21.32%17.76%
Effective Tax Rate
26.63%26.38%27.72%27.35%51.12%36.72%
Revenue as Reported
39,50838,95135,76333,52433,53830,362
Advertising Expenses
-1,2021,0941,0911,277673.72
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.